Chimeric anti-tenascin antibody 81C6: Increased tumor localization compared with its murine parent

This publication has 20 references indexed in Scilit:

• Catabolism of radioiodinated murine monoclonal antibody F(ab')2 fragment labeled using N-succinimidyl 3-iodobenzoate and Iodogen methods
  Bioconjugate Chemistry, 1995
• Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab?)2-a preliminary report
  Journal of Neuro-Oncology, 1995
• Application of high affinity binding concept to radiolabel avidin with Tc-99m labeled biotin and the effect of pI on biodistribution
  Nuclear Medicine and Biology, 1994
• Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin
  Journal of Neuroimmunology, 1994
• Phase I trial of chimeric (human-mouse) monoclonal antibody L6 in patients with non-small-cell lung, colon, and breast cancer
  Cancer Immunology, Immunotherapy, 1993
• Biodistribution of anti-CEA F(ab′)2 fragments conjugated with chelating polymers: Influence of conjugate electron charge on tumor uptake and blood clearance
  Nuclear Medicine and Biology, 1993
• Response of glioblastoma cell lines to low dose rate irradiation
  International Journal of Radiation Oncology*Biology*Physics, 1991
• Development of human anti‐murine antibody (HAMA) response in patients
  Immunology & Cell Biology, 1990
• Generation of a recombinant mouse‐human chimaeric monoclonal antibody directed against human carcinoembryonic antigen
  International Journal of Cancer, 1989
• Synthesis of radioiodinated N-succinimidyl iodobenzoate: Optimization for use in antibody labelling
  International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1989